Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of published randomized trials

Ibrahim Ezzeldin M

Year : 2010| Volume: 5| Issue : 3 | Page no: 153-160

   This article has been cited by
 
1 Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials
Wei-Xiang Qi,Shen Fu,Qing Zhang,Xiao-Mao Guo
Current Medical Research and Opinion. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Clinical meta-analyses of targeted therapies in adenocarcinoma
Bria, E. and Bonomi, M. and Pilotto, S. and Massari, F. and Novello, S. and Levra, M.G. and Tortora, G. and Scagliotti, G.
Targeted Oncology. 2013; 8(1): 35-45
[Pubmed]  [Google Scholar]
3 Clinical meta-analyses of targeted therapies in adenocarcinoma
Emilio Bria,Maria Bonomi,Sara Pilotto,Francesco Massari,Silvia Novello,Matteo Giaj Levra,Giampaolo Tortora,Giorgio Scagliotti
Targeted Oncology. 2013; 8(1): 35
[Pubmed]  [Google Scholar] [DOI]
4 Cetuximab-based Therapy is Effective in Chemotherapy-nave Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials
Ezzeldin M. Ibrahim,Khaled M. Abouelkhair,Osama A. Al-Masri,Najeeb C. Chaudry,Ghieth A. Kazkaz
Lung. 2011; 189(3): 193
[Pubmed]  [Google Scholar] [DOI]
5 Cetuximab-based therapy is effective in chemotherapy-nave patients with advanced and metastatic non-small-cell lung cancer: A meta-analysis of randomized controlled trials
Ibrahim, E.M., Abouelkhair, K.M., Al-Masri, O.A., Chaudry, N.C., Kazkaz, G.A.
Lung. 2011; 189(3): 193-198
[Pubmed]  [Google Scholar]
6 Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
Dunn, K.B., Heffler, M., Golubovskaya, V.M.
Anti-Cancer Agents in Medicinal Chemistry. 2010; 10(10): 722-734
[Pubmed]  [Google Scholar]

 

Read this article